Incyte Can’t Keep Sun’s Hair Drug Off Market, Appeals Court Says

Sun Pharmaceutical Industries Ltd. can launch its new hair-loss drug Leqselvi after the Federal Circuit reversed a district judge’s order granting Incyte Corp. an injunction blocking the release over a patented but unapproved competing treatment.

Incyte didn’t show it would suffer real harm if Sun entered the market, especially since Incyte’s version of the alopecia drug isn’t expected to be available until years after US Patent No. 9,662,335 expires in December 2026, Chief Judge Kimberly A. Moore wrote in an opinion issued Wednesday by the US Court of Appeals for the Federal Circuit.

The three-judge panel lifted the injunction in ...